Department of Health and Human Services October 19, 2022 – Federal Register Recent Federal Regulation Documents

Eunice Kennedy Shriver National Institute of Child Health and Human Development; Notice of Meetings
Document Number: 2022-22647
Type: Notice
Date: 2022-10-19
Agency: Department of Health and Human Services, National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed Meeting
Document Number: 2022-22645
Type: Notice
Date: 2022-10-19
Agency: Department of Health and Human Services, National Institutes of Health
Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Premarket Tobacco Product Applications and Recordkeeping Requirements
Document Number: 2022-22708
Type: Notice
Date: 2022-10-19
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Use of Tracers in Animal Food, Type A Medicated Articles, and Medicated Feeds; Guidance for Industry; Availability
Document Number: 2022-22705
Type: Notice
Date: 2022-10-19
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry (GIF) 258 entitled ``Use of Tracers in Animal Food, Type A Medicated Articles, and Medicated Feeds.'' Tracers are ingredients added to animal food, medicated feed, and Type A medicated articles to identify a particular product. The purpose of this document is to provide guidance on the use of tracers in animal food, medicated feeds, and Type A medicated articles. This final guidance replaces Compliance Policy Guide (CPG) Sec. 680.100 ``Tracers in Animal Feed.''
Pulmonary-Allergy Drugs Advisory Committee; Amendment of Notice
Document Number: 2022-22700
Type: Notice
Date: 2022-10-19
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing an amendment to the notice of meeting of the Pulmonary-Allergy Drugs Advisory Committee. This meeting was announced in the Federal Register of September 8, 2022. The amendment is being made to reflect changes in the DATES, ADDRESSES, and SUPPLEMENTARY INFORMATION portions of the document. The meeting was rescheduled to allow time for FDA to review new information submitted to the application. There are no other changes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.